Ascendis Pharma A ASND
NASDAQ ASND
$227.31 -0.52 (-0.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Long-Term Debt Issuances (2022 - 2023)

Updated

Ascendis Pharma A's Long-Term Debt Issuances was $145.2 million in the year ended Dec 31, 2024, down 1.5% from $147.39 million a year earlier.

Analysis

Ascendis Pharma A (ASND) Long-Term Debt Issuances (2022 - 2023) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $147.39 million in the year ended Dec 31, 2023 (-72.2%) and $530.44 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Ascendis Pharma A 14.12 Bn 10.37 Bn 362.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -3.79 Mn
Sep 30, 2023 152.17 Mn
Jun 30, 2022 -1.25 Mn
Mar 31, 2022 566.17 Mn
API Access

Ascendis Pharma A Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ASND&period=max&api_key=YOUR_API_KEY